| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.051 | 0.08 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.049 | 0.09 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.3 | 0.09 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.09 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |